Antibody-drug conjugates (ADCs) may be a big breakthrough in gynecologic cancer treatment (I)

被引:4
|
作者
Wang, Peng-Hui [1 ,2 ,3 ,4 ]
Liu, Chia-Hao [1 ,2 ,3 ]
Yang, Szu-Ting [4 ]
机构
[1] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, 201 Sect 2,Shih Pai Rd, Taipei 11217, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Female Canc Fdn, Taipei, Taiwan
[4] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
来源
关键词
FRONT-LINE CHEMOIMMUNOTHERAPY; PART II; RECURRENT;
D O I
10.1016/j.tjog.2024.09.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:817 / 819
页数:3
相关论文
共 50 条
  • [21] Antibody-drug conjugates (ADCs) - New targeted therapies
    Papakonstantinou G.
    memo - Magazine of European Medical Oncology, 2013, 6 (4) : 223 - 224
  • [22] Antibody-drug conjugates for the treatment of ovarian cancer
    Calo, Corinne A.
    O'Malley, David M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 875 - 887
  • [23] Antibody-Drug Conjugates for the Treatment of Breast Cancer
    Corti, Chiara
    Giugliano, Federica
    Nicolo, Eleonora
    Ascione, Liliana
    Curigliano, Giuseppe
    CANCERS, 2021, 13 (12)
  • [24] Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies
    Jiang, Yuying
    Xu, Yuance
    He, Junqi
    Sui, Lei
    Li, Tian
    Xia, Nannan
    Yao, Qin
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [25] Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy
    Hartley, John A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 931 - 943
  • [26] Antibody-Drug Conjugates (ADCs) in Breast Cancer: Real World Analysis of Outcomes
    Raghavendra, Akshara Singareeka
    Wang, Zhongya
    Bassett, Roland
    Tripathy, Debu
    CANCER RESEARCH, 2024, 84 (09)
  • [27] Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer
    Belluomini, Lorenzo
    Avancini, Alice
    Sposito, Marco
    Milella, Michele
    Rossi, Antonio
    Pilotto, Sara
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (11) : 1077 - 1087
  • [28] Antibody-drug conjugates for cancer
    Chau, Cindy H.
    Steeg, Patricia S.
    Figg, William D.
    LANCET, 2019, 394 (10200): : 793 - 804
  • [29] New peptide-linked anilino-maytansinoid antibody-drug conjugates (ADCs) for the treatment of cancer
    Widdison, Wayne C.
    Ponte, Joe
    Coccia, Jennifer
    Setiady, Yulius
    Dong, Ling
    Skaletskaya, Anja
    Fishkin, Nathan
    Kovtun, Yelena
    Wu, Rui
    Singh, Rajeeva
    Harris, Luke
    Jones, Greg
    Lanieri, Leanne
    Maloney, Erin
    Audette, Charlene
    Dandeneau, Andre
    Chari, Ravi
    Costoplus, Juliet
    Veale, Karen
    Wilhelm, Sharon
    CANCER RESEARCH, 2014, 74 (19)
  • [30] The evolving landscape of antibody-drug conjugates in gynecologic cancers
    Tolcher, Anthony
    Hamilton, Erika
    Coleman, Robert L.
    CANCER TREATMENT REVIEWS, 2023, 116